(1 - 30 von 50
)
UNITY Biotechnology, Inc. to Announce First Quarter Financial...
edition.cnn.com
View market sector performance relative to the S&P 500 Index and trended stock performance over time.
Il Consiglio di amministrazione annuncia che Response Genetics Inc....
www.informazione.it
Peter Rahmer, + (Contatti con gli investitori) oppure. Fleishman Facebook Twitter GooglePlus Pinterest Linkedin Tumblr.
ISS Recommends That Response Genetics Shareholders Vote Management's...
www.finanznachrichten.de
Glass Lewis Also Recommends that Shareholders Vote the GOLD Card and Against the Change of Control Proposed by Dissidents Response Genetics, Inc.
Response Genetics, Inc. to Release Fourth Quarter and Full-Year
www.finanznachrichten.de
Contacts: Investor Relations: Trout Group Peter Rahmer, or. Media Relations: Fleishman-Hillard Barry Sudbeck,
Response Genetics, Inc. to Release Third Quarter Financial...
www.finanznachrichten.de
Contacts: Trout Group Peter Rahmer, (Investor Relations) or. Fleishman-Hillard Barry Sudbeck, (Media Relations) ...
Biopharma Stock News: Zai Lab Investorideas.comwww.investorideas.com › news › biotech
www.investorideas.com
, Investors: Peter Rahmer / Mike Zanoni Endurance Advisors, on behalf of Zai Lab
Close Biotechgate Biotechgate | | Twitter LinkedIn Google+ ...www.biotechgate.com › gate › news_details
www.biotechgate.com
Company: Lauren Cohen Director, Corporate Communications . Investors: Peter Rahmer Endurance Advisors, LLC
AlipesNews - Response Genetics, Inc. Announces Contract With Blue...
www.alipesnews.com
AlipesNews keeps you updated on financial news the split-second they break
Regeneron and Zai Lab Announce Regional Strategic ...www.gurufocus.com › news
www.gurufocus.com
/ . Investors: Peter Rahmer / Mike Zanoni Endurance Advisors, on behalf of Zai Lab
Stockwatch
www.stockwatch.com
No Hype - just the Facts. Your complete source of news and realtime quotes from the TSX, TSX-V, CSE, Montreal, Nasdaq, NYSE, Amex and OTC Markets.
Loxo Oncology Announces Selection of LOXO-101 for NCI-MATCH Precision...
www.globenewswire.com
“We are honored that an independent committee of the NCI-MATCH trial has selected LOXO-101 for the TRK fusion arm of the ... Peter Rahmer
Loxo Oncology Announces Transition of Chief Medical Officer
www.globenewswire.com
... Development and Strategy Investors: Peter Rahmer The Trout Group, LLC
Loxo Oncology Appoints Alan Fuhrman to Board of Directors
www.globenewswire.com
He will serve as an independent director and chair the audit committee. Coincident with Mr. Fuhrman's ... Peter Rahmer The Trout Group, LLC
Loxo Oncology to Announce First Quarter Financial Results...
www.globenewswire.com
Peter Rahmer The Trout Group, LLC Media: Dan Budwick Pure Communications, Inc
| Press Release | Loxo Oncology Announces Receipt of...
stockhouse.com
Loxo Oncology Announces Receipt of Breakthrough Therapy Designation from U.S. Food and Drug Administration for LOXO-292
UNITY Biotechnology, Inc. To Announce Second Quarter Financial...
www.globalbankingandfinance.com
More information is available at www.unitybiotechnology.com or follow us on Twitter. Investors Endurance Advisors Peter Rahmer.
Up and Over 10K - CCR Timingwww.ccrtiming.com › results
www.ccrtiming.com
:55 M4049 AG Joel Gonzalez 32 Albuquerque NM 1:14: :55 M3039 AG Peter Rahmer 33 San Fransico CA 1:14: :55 M
Loxo Oncology Announces Pricing of Initial Public Offering
www.globenewswire.com
Jacob S. Van Naarden Vice President, Corporate Development and Strategy Peter Rahmer The Trout Group, LLC Related ...
UNITY Biotechnology, Inc. to Announce First Quarter Financial...
ir.unitybiotechnology.com
More information is available at www.unitybiotechnology.com or follow us on Twitter. Investors Endurance Advisors Peter Rahmer / Mike Zanoni
Zai Lab Announces Acceptance of NDA Submission of ...zailab.gcs-web.com › news-releases
zailab.gcs-web.com
, Investors: Peter Rahmer / Mike Zanoni Endurance Advisors, on behalf of Zai Lab
UNITY Biotechnology, Inc. to Participate in the Cantor ...www.globenewswire.com › UNIT...
www.globenewswire.com
... is available at www.unitybiotechnology.com or follow us on Twitter. Investors Endurance Advisors Peter Rahmer Media Jason Spark ...
UNITY Biotechnology, Inc. to Present at Upcoming Investor
www.globenewswire.com
... www.unitybiotechnology.com or follow us on Twitter. Investors Endurance Advisors Peter Rahmer . Media
Zai Lab Announces Acceptance of NDA Submission of ...ir.zailaboratory.com › news-releases
ir.zailaboratory.com
, Investors: Peter Rahmer / Mike Zanoni Endurance Advisors, on behalf of Zai Lab
Home Page - Hungarian Biotech Database
www.hungarianbiotech.com
Close. Biotechgate Biotechgate. | |. Twitter · LinkedIn · Google+. Companies Investors The Trout Group Peter Rahmer, prahmer@troutgroup.
Home Page - Maltese Biotech Database
www.maltesebiotech.com
Close. Biotechgate Biotechgate. | |. Twitter LinkedIn Google+. Companies Peter Rahmer. Thomas A. Bologna. Trout Group. Response Genetics, Inc
Loxo Oncology Announces Completion of Clinical Trial
www.globenewswire.com
... as determined by independent radiology review, for NTRK fusion patients enrolled across the three ongoing larotrectinib ... Peter Rahmer
Loxo Oncology Announces Completion of Clinical Trial Enrollment for...
www.einnews.com
Peter Rahmer The Trout Group, LLC (a press release distribution service). Follow us on Facebook & Twitter and connect with us on LinkedIn.
Response Genetics, Inc. : Announces Contracts With Two Additional...
www.marketscreener.com
LOS ANGELES, Dec. 18, Response Genetics, Inc. , a company focused on the development and sale of molecular diagnostic tests that help determine a...
sortiert nach Relevanz / Datum